Twelve Points Wealth Management LLC Gilead Sciences, Inc. Transaction History
Twelve Points Wealth Management LLC
- $391 Million
- Q3 2025
A detailed history of Twelve Points Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Twelve Points Wealth Management LLC holds 5,439 shares of GILD stock, worth $674,925. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,439
Previous 6,499
16.31%
Holding current value
$674,925
Previous $720,000
16.25%
% of portfolio
0.15%
Previous 0.2%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,366Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...